Adelaide Research & Scholarship: Search

Search

Results 1-8 of 8 (Search time: 0.003 seconds).

previous
1
next

Item hits:

Preview	Issue Date	Title	Author(s)
	1999	Expression and characterization of wild type and mutant recombinant human sulfamidase - Implications for Sanfilippo (mucopolysaccharidosis IIIA) syndrome	Perkins, K.; Byers, S.; Yogalingam, G.; Weber, B.; Hopwood, J.
	2007	Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI	Auclair, D.; Hopwood, J.; Lemontt, J.; Chen, L.; Byers, S.
	1996	Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome	Crawley, A.; Brooks, D.; Muller, V.; Petersen, B.; Isaac, E.; Bielicki, J.; King, B.; Boulter, C.; Moore, A.; Fazzalari, N.; Anson, D.; Byers, S.; Hopwood, J.
	1998	Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies	Bunge, S.; Clements, P.; Byers, S.; Kleijer, W.; Brooks, D.; Hopwood, J.
	2006	Intra-articular enzyme administration for joint disease in feline mucopolysaccharidosis VI: Enzyme dose and interval	Auclair, D.; Hein, L.; Hopwood, J.; Byers, S.
	2004	Monitoring dose response of enzyme replacement therapy in feline mucopolysaccharidosis type VI by tandem mass spectrometry	Crawley, A.; Ramsay, S.; Byers, S.; Hopwood, J.; Meikle, P.
	2000	Enzyme replacement therapy in a feline model of MPS VI: Modification of enzyme structure and dose frequency	Byers, S.; Crawley, A.; Brumfield, L.; Nuttall, J.; Hopwood, J.
	1997	Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models	Brooks, D.; King, B.; Crawley, A.; Byers, S.; Hopwood, J.